Aquestive Therapeutics Q2 EPS $(0.10) Beats $(0.11) Estimate, Sales $13.24M Beat $10.76M Estimate
Portfolio Pulse from bharat@benzinga.com
Aquestive Therapeutics reported Q2 earnings per share of $(0.10), beating the estimate of $(0.11) by 9.09%. This is a 72.22% increase over the same period last year. The company also reported sales of $13.24M, beating the estimate of $10.76M by 23.06%, although this is a slight decrease of 0.18% from last year.
August 07, 2023 | 8:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aquestive Therapeutics reported better than expected Q2 earnings and sales, which could positively impact the stock.
Aquestive Therapeutics reported better than expected Q2 earnings and sales. This positive financial performance could increase investor confidence and demand for the stock, potentially driving its price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100